Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall tone demonstrates strong support and excitement, with phrases like 'great work' and 'collaborative research' emphasizing its relevance. Examples such as references to the discovery of a 'potent, ultra-selective CDK9 inhibitor' and appreciation for applying 'novel drug discovery techniques' highlight the perceived importance and innovative nature of the study, with words and tone reflecting optimism and acknowledgment of its potential impact in oncology.
Most discussions express support and recognition for the significance of the research findings.
The discussions show a high level of interest, with multiple mentions of collaboration, novelty, and potential implications.
Replies include appreciation for the researchers' work, mentions of the techniques used, and comments on the importance of the findings, indicating a moderate level of engagement.
The recognition of this research as a promising approach to treating resistant prostate cancer suggests a meaningful impact in the field.
Modulating Androgen Receptor-driven Transcription in Prostate Cancer with Selective #CDK9 #Inhibitors @CellChemBiol from Angel Koehler's lab @kochinstitute at @MIT. #AACR21 https://t.co/A02iFfqot0
. @AndreRichters and @shelbykatdoyle in the Koehler lab at the @kochinstitute have discovered a potent, ultra-selective CDK9 inhibitor that modulates androgen receptor-transcription in #ProstateCancer. https://t.co/QTWo7qJyYn https://t.co/D8H27ozOW9
Well done to Ian Hickson for his published work "Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors" collaborating with Angela Koehler's lab at the Koch University. @NU_Cancer https://t.co/eqwhiiNklw
Great to see this work published today. Collaborative research, applying novel drug discovery techniques to an old foe and finding new targets! Great work everyone: Angela Koehler's lab @AndreRichters @kochinstitute @shelbykatdoyle @KronosBio @MIT https://t.co/LHhsMSJKc7
RT @CellPressNews: Modulating Androgen Receptor-driven Transcription in Prostate Cancer with Selective #CDK9 #Inhibitors @CellChemBiol from…
RT @CellPressNews: Modulating Androgen Receptor-driven Transcription in Prostate Cancer with Selective #CDK9 #Inhibitors @CellChemBiol from…
This video explores molecular modeling and dynamic simulations of the Claudin 6 antigen-antibody complex. Using advanced software like VMD and NAMD, it demonstrates simulating large biological structures and discusses…
This video explores molecular modeling and dynamic simulations of KB-0742 targeting Cdk9 kinase, using VMD, NAMD, OpenMM, and Google Colab. The study highlights the role of halogen bonds in achieving selective…
This video demonstrates molecular dynamic simulations of the Claudin 6 antigen antibody complex, utilizing computational chemistry methods, protein structure prediction, and GPU-accelerated platforms for insights into…
Brief molecular dynamic simulation of a hypothesized Zotatifin-eIF4A-Polypurine RNA complex. Zotatifin, an eIF4A helicase inhibitor in clinical trials, was modeled with initial conditions including Roca binding and…
This brief molecular dynamics simulation investigates 2Deoxy6Thioguanosine Phosphate's interaction with telomerase and telomeric DNA, using software like VMD, NAMD, and OpenMM to model and analyze the complex's…
RT @CellPressNews: Modulating Androgen Receptor-driven Transcription in Prostate Cancer with Selective #CDK9 #Inhibitors @CellChemBiol from…
RT @CellPressNews: Modulating Androgen Receptor-driven Transcription in Prostate Cancer with Selective #CDK9 #Inhibitors @CellChemBiol from…
Modulating Androgen Receptor-driven Transcription in Prostate Cancer with Selective #CDK9 #Inhibitors @CellChemBiol from Angel Koehler's lab @kochinstitute at @MIT. #AACR21 https://t.co/A02iFfqot0
. @AndreRichters and @shelbykatdoyle in the Koehler lab at the @kochinstitute have discovered a potent, ultra-selective CDK9 inhibitor that modulates androgen receptor-transcription in #ProstateCancer. https://t.co/QTWo7qJyYn https://t.co/D8H27ozOW9
Well done to Ian Hickson for his published work "Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors" collaborating with Angela Koehler's lab at the Koch University. @NU_Cancer https://t.co/eqwhiiNklw
New article: Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors. https://t.co/EKyOOjWexB #prostatecancer #oncology https://t.co/gy2RAqQESK
Great to see this work published today. Collaborative research, applying novel drug discovery techniques to an old foe and finding new targets! Great work everyone: Angela Koehler's lab @AndreRichters @kochinstitute @shelbykatdoyle @KronosBio @MIT https://t.co/LHhsMSJKc7